Robin L. Washington

2012

In 2012, Robin L. Washington earned a total compensation of $4.2M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$728,875
Option Awards$1,477,368
Salary$693,356
Stock Awards$1,268,494
Other$7,500
Total$4,175,593

Washington received $1.5M in option awards, accounting for 35% of the total pay in 2012.

Washington also received $728.9K in non-equity incentive plan, $693.4K in salary, $1.3M in stock awards and $7.5K in other compensation.

Rankings

In 2012, Robin L. Washington's compensation ranked 1,560th out of 11,487 executives tracked by ExecPay. In other words, Washington earned more than 86.4% of executives.

ClassificationRankingPercentile
All
1,560
out of 11,487
86th
Division
Manufacturing
558
out of 4,253
87th
Major group
Chemicals And Allied Products
121
out of 1,198
90th
Industry group
Drugs
65
out of 920
93rd
Industry
Biological Products, Except Diagnostic Substances
9
out of 160
94th
Source: SEC filing on March 27, 2015.

Washington's colleagues

We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2012.

2012

John Martin

Gilead Sciences

Chief Executive Officer

2012

John Milligan

Gilead Sciences

Chief Operating Officer

2012

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2012

Kevin Young

Gilead Sciences

Former Executive Vice President, Commercial Operations

News

You may also like